An ambition of the chemical approach is to reorganize pharmacological maps, associations among proteins, on the basis of ligand similarities rather than sequence, structural, or pathway similarities.
As a result of the reconstruction process, one new gene was annotated and 16 other genes were identified to be missing, implying either non-conserved amino acids sequences or possibly new pathways.
Linking the components to external data resources, such as protein sequences from UniProt [ 9] or pathways from Reactome [ 10], can allow the unambiguous identification of the components.
This indicates either that TET3 is not targeted to these sequences or that alternative demethylation pathways operate redundantly or are recruited to noncanonical targets to compensate for the absence of TET3 oxidation.
The unigenes were then assigned to putative functions, classifications or pathways based on sequence similarity analysis against the sequences in the public database resources.
Proteins encoded in the genomic sequences form biochemical pathways and pathways join together to form networks.
A sequence of reactions, or pathway, is an EFM if and only if it meets the following three conditions.
This method modifies and extends the previously-described SCARVA technique, which is haplotyped-based, for use with marker-level data in a given region (which could be defined by a gene, target sequence, window size, or pathway involving multiple genes).
Having said this, the resource will facilitate the assignment of genomic or protein sequences to the pathways that impact on osmoprotectant compounds.
